🕐 🆕
www.abfjournal.com
22/06/2026
Dyne Therapeutics Expands Debt Facility of Up to $400MM with Hercules Capital
Dyne Therapeutics, a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, entered into an amendment to its non-dilutive senior secured term loan facility with Hercules C